Non-alcoholic fatty liver disease and cognitive impairment
Aim. To evaluate the efficacy of oral administration of the original ademetionine (Geptral) at a dose of 1500 mg/s in patients with NAFLD at the steatosis stage and cognitive impairment within the framework of a prospective observational open non-comparative study in real clinical practice against t...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
"Consilium Medicum" Publishing house
2024-12-01
|
| Col·lecció: | Терапевтический архив |
| Matèries: | |
| Accés en línia: | https://ter-arkhiv.ru/0040-3660/article/viewFile/656035/pdf |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|